As enrollment in Medicare Advantage is expected to increase to a new all-time high for the sixth year in a row, CMS announced that Medicare Advantage premiums will remain stable in 2016.
As enrollment in Medicare Advantage (MA) is expected to increase to a new all-time high for the sixth year in a row, CMS announced that MA premiums will remain stable in 2016.
According to new information from CMS, the average MA premium will decrease from $32.91 in 2015 to $32.60 in 2016. Overall, 59% of enrollees will face no premium increase at all.
“Seniors and people with disabilities continue to experience stable premiums in Medicare health and drug plans while benefiting from a transparent and competitive marketplace,” Sean Cavanaugh, CMS deputy administrator and director of the Center for Medicare, said in a statement. “Medicare Advantage and prescription drug plans remain affordable and provide high quality care.”
Since the passage of the Affordable Care Act in 2010, MA premiums are expected to have decreased nearly 10% while enrollment increases by more than 50%. At approximately 17.4 million enrollees, MA represents one-third of the Medicare population.
Nearly two-thirds of MA enrollees are in plans with at least 4 stars for 2016, an indication that beneficiaries are receiving higher quality care—in 2009 just 17% of enrollees were in plans with 4 or more stars.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
American Advocacy and Action for Minority Health in 2025
April 4th 2025Accessing equitable health care is an ongoing struggle in the US for minority communities due to historical pretexts with new setbacks surfacing as recent administrative changes emerge, highlighting the urgent need for continued advocacy during National Minority Health Month.
Read More
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
American Advocacy and Action for Minority Health in 2025
April 4th 2025Accessing equitable health care is an ongoing struggle in the US for minority communities due to historical pretexts with new setbacks surfacing as recent administrative changes emerge, highlighting the urgent need for continued advocacy during National Minority Health Month.
Read More
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More
2 Commerce Drive
Cranbury, NJ 08512